Peer-influenced content. Sources you trust. No registration required. This is HCN.

Childhood ObesityNutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists

ℹ️ Observational Association Only Evidence

Researchers analyzed administrative claims for 2,031 patients aged 10 to 17 years who initiated GLP-1 receptor agonist therapy without a recently recorded nutritional deficiency. Within 12 months, 16.8% received at least one nutritional-deficiency or related-complication diagnosis. Only 23.3% had nutrition therapy or counseling within 180 days. The study describes real-world diagnosis and utilization patterns but cannot determine whether treatment caused deficiencies or whether counseling changed outcomes.


Clinical Considerations

  • Vitamin D deficiency dominated the observed signal, rising from 7.6% at six months to 12.4% at one year.
  • Nutritional anemia affected 1.5%, iron-deficiency anemia affected 1.4%, and dehydration affected 2.6% within one year.
  • Only 5.8% received nutrition care within 30 days; mean time to the first documented encounter was 149 days.
  • Higher deficiency rates among patients receiving counseling likely reflect reactive referral or greater detection, not harm from nutrition care.
  • Claims codes cannot capture dietary intake, laboratory-confirmed deficiencies, growth trajectories, lean mass changes, or unbilled counseling.
  • The 2017–2022 cohort predominantly received liraglutide, limiting generalizability to current semaglutide and tirzepatide prescribing patterns.

Practice Applications

  • Consider nutritional history and baseline risk assessment when adolescents begin GLP-1 receptor agonist treatment.
  • Monitor growth, dietary adequacy, gastrointestinal intolerance, hydration, and clinically indicated micronutrient markers during follow-up.
  • Discuss adequate protein, iron, calcium, and vitamin D intake without interpreting claims-based associations as supplementation guidance.
  • Integrate timely dietitian involvement when access permits, while recognizing that prospective evidence has not defined optimal referral timing.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form